Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GADOBUTROL
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
- Novel Imaging Technique to Assess Cervical Cancer
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
- PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
- Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
- Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
- Dotarem vs Gadobutrol Contrast for Breast MRI
- Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose
- Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
- Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
- CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
- Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
- Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study
- The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
- Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
- Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
- Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
- Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
- Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)
- Gadobutrol Enhanced MRA of the Renal Arteries
- Gadobutrol Enhanced MRA of the Supra-aortic Vessels
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
- Gadobutrol Magnevist-controlled Body Study
- Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
- Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging
- Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
- Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
- Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
- Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging
- SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Clinical trials list
click for details